Business Context and Reporting Period
Company: Cree, Inc. (Note: The filing metadata references "WOLFSPEED, INC.", but the document text identifies the registrant as Cree, Inc., a North Carolina corporation established in 1987. Cree is the world leader in developing and manufacturing compound semiconductor materials and devices made from silicon carbide (SiC) and gallium nitride (GaN).)
Reporting Period: Fiscal year ended June 24, 2001.
Segments: The company operates in two segments: the Cree segment (SiC-based products including LEDs, wafers, and power devices) and the UltraRF segment (silicon-based RF transistors and amplifiers acquired in December 2000).
Key Financial Metrics
| Metric | Fiscal 2001 | Fiscal 2000 |
|---|---|---|
| Total Revenue | $177.2 million | $108.6 million |
| Net Income | $27.8 million | $30.5 million |
| Diluted EPS | $0.37 | $0.43 |
| Gross Margin | 49.4% | 51.8% |
| Operating Cash Flow | $74.8 million | $63.0 million |
| Working Capital | $244.2 million | $266.0 million |
| Cash & Equivalents | $164.6 million | $103.8 million |
| Long-term Debt | $0 | $0 |
Revenue Composition (Fiscal 2001): LED products (65%), Material products (14%), RF/Microwave (11%), and Contract revenue (10%).
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 63% to $177.2 million, driven by a 65% increase in product revenue. LED chip volume doubled (104% growth), though average sales prices declined 18%.
- Profitability Decline: Net income decreased 9% to $27.8 million despite revenue growth. Gross margins compressed from 51.8% to 49.4% due to price erosion outpacing cost reductions and lower yields on new products.
- Acquisition Impact: The acquisition of UltraRF (December 2000) contributed $19.2 million in revenue but included a one-time charge of $17.4 million for in-process research and development costs, significantly impacting operating income.
- Expense Increases: R&D expenses rose 84% to $13.0 million and SG&A expenses rose 63% to $18.1 million, largely attributable to the UltraRF acquisition and increased litigation costs.
- Investment Impairment: A $4.6 million write-down was recorded on private company investments deemed "other than temporary" impairments.
Guidance, Outlook, and Risks
Outlook: Management targets stable LED volume in the first half of fiscal 2002 with a ramp-up in the second half driven by new design wins for the MegaBright(TM) product line. The UltraRF segment is expected to remain stable at 20-30% of total revenue.
Key Risks and Contingencies:
- Intellectual Property Litigation: Ongoing patent disputes with Nichia Corporation in Japan and the U.S. regarding LED technology. While Cree won a recent ruling in Japan, Nichia has appealed. Adverse outcomes could restrict sales or require licensing fees.
- Customer Concentration: The top five customers accounted for 72% of total revenue in fiscal 2001. Loss of a major customer could materially impact results.
- Production Yields: Margins are sensitive to manufacturing yields. New product introductions (MegaBright) have faced yield challenges, increasing unit costs.
- Government Funding: Approximately 10% of revenue is derived from U.S. Government contracts, which can be terminated at the government's convenience.
Investor Verification Checklist
- Verify the status of the patent litigation with Nichia Corporation, specifically the appeal of the Tokyo District Court ruling and the U.S. counterclaims.
- Monitor the production yield rates and cost-per-unit trends for the new MegaBright(TM) LED products to assess margin recovery potential.
- Review the diversification progress of the UltraRF segment to reduce reliance on Spectrian (which accounted for over 90% of UltraRF revenue).
- Assess the impact of the $4.6 million investment impairment and the valuation of remaining private equity holdings.
- Confirm the timeline for the transition from two-inch to three-inch wafers and associated yield risks.